Erianin Exerts Antineoplastic Effects on Esophageal Squamous Cell Carcinoma Cells by Activating the cGMP-PKG Signaling Pathway

References

• Zhou S, Sun X, Jin Z, Yang H, Ye W. The role of autophagy in initiation, progression, TME modification, diagnosis, and treatment of esophageal cancers. Crit Rev Oncol Hematol. 2022;175:103702. doi: 10.1016/j.critrevonc.2022.103702.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zheng R, Zhang S, Chen R, Wang S, Sun K, Li M, Lei S, Zhuang G, Wei W. Gastric and esophageal cancer in China 2000 to 2030: recent trends and short-term predictions of the future burden. Cancer Med. 2022;11(8):1902–12. doi: 10.1002/cam4.4586.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhao W, Li J, Hu P, Zhao Y, Tse LA, Lu J, Ren Z, Xing X, Liu X. Association of dietary phytosterols intake and survival of esophageal squamous cell carcinoma: a prospective cohort study. Nutr Cancer. 2022;74(10):3582–91. doi: 10.1080/01635581.2022.2085311.
   PubMed Web of Science ®Google Scholar
• Qiao Q, Du Y, Xie L. Research advances of erianin: source, production, biological activities and pharmacological properties. Pharmacol Res-Modern Chin Med. 2022;2:100059. doi: 10.1016/j.prmcm.2022.100059.
   Google Scholar
• Hong J, Xie Z, Yang F, Jiang L, Jian T, Wang S, Guo Y, Huang X. Erianin suppresses proliferation and migration of cancer cells in a pyruvate carboxylase-dependent manner. Fitoterapia. 2022;157:105136. doi: 10.1016/j.fitote.2022.105136.
   PubMed Web of Science ®Google Scholar
• Zhang H-Q, Xie X-F, Li G-M, Chen J-R, Li M-T, Xu X, Xiong Q-Y, Chen G-R, Yin Y-P, Peng F, et al. Erianin inhibits human lung cancer cell growth via PI3K/Akt/mTOR pathway in vitro and in vivo. Phytother Res. 2021;35(8):4511–25. doi: 10.1002/ptr.7154.
   PubMed Web of Science ®Google Scholar
• Yang L, Hu Y, Zhou G, Chen Q, Song Z. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways. Biosci Rep. 2020;40(7):BSR20193137. doi: 10.1042/BSR20193137.
   PubMed Web of Science ®Google Scholar
• Xu Y, Fang R, Shao J, Cai Z. Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway. Biosci Rep. 2021;41(6):BSR20210093. doi: 10.1042/BSR20210093.
   PubMed Web of Science ®Google Scholar
• Chen P, Wu Q, Feng J, Yan L, Sun Y, Liu S, Xiang Y, Zhang M, Pan T, Chen X, et al. Erianin, a novel dibenzyl compound in dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis. Signal Transduct Target Ther. 2020;5(1):51. doi: 10.1038/s41392-020-0149-3.
   PubMed Web of Science ®Google Scholar
• Gambaryan S. The role of NO/sGC/cGMP/PKG signaling pathway in regulation of platelet function. Cells. 2022;11(22):3704. doi: 10.3390/cells11223704.
   PubMed Web of Science ®Google Scholar
• Lehners M, Dobrowinski H, Feil S, Feil R. cGMP signaling and vascular smooth muscle cell plasticity. JCDD. 2018;5(2):20. doi:10.3390/jcdd5020020.
   Web of Science ®Google Scholar
• Degjoni A, Campolo F, Stefanini L, Venneri MA. The NO/cGMP/PKG pathway in platelets: the therapeutic potential of PDE5 inhibitors in platelet disorders. J Thromb Haemost. 2022;20(11):2465–74. doi: 10.1111/jth.15844.
   PubMed Web of Science ®Google Scholar
• Bhargava P, Janda J, Schnellmann RG. Elucidation of cGMP-dependent induction of mitochondrial biogenesis through PKG and p38 MAPK in the kidney. Am J Physiol Renal Physiol. 2020;318(2):F322–F328. doi: 10.1152/ajprenal.00533.2019.
   PubMed Web of Science ®Google Scholar
• Piazza GA, Ward A, Chen X, Maxuitenko Y, Coley A, Aboelella NS, Buchsbaum DJ, Boyd MR, Keeton AB, Zhou G. PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity. Drug Discov Today. 2020;25(8):1521–7. doi: 10.1016/j.drudis.2020.06.008.
   PubMed Web of Science ®Google Scholar
• Feil R, Lehners M, Stehle D, Feil S. Visualising and understanding cGMP signals in the cardiovascular system. Br J Pharmacol. 2022;179(11):2394–412. doi: 10.1111/bph.15500.
   PubMed Web of Science ®Google Scholar
• Li W, Yin X, Yan Y, Liu C, Li G. STEAP4 knockdown inhibits the proliferation of prostate cancer cells by activating the cGMP-PKG pathway under lipopolysaccharide-induced inflammatory microenvironment. Int Immunopharmacol. 2021;101(Pt B):108311. doi: 10.1016/j.intimp.2021.108311.
   PubMed Web of Science ®Google Scholar
• Ren Y, Zheng J, Yao X, Weng G, Wu L. Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells. Int J Mol Med. 2014;34(5):1430–8. doi: 10.3892/ijmm.2014.1925.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu G, Liu M, Cai Q, Yao C, Chen H, Song N, Yuan C, Tan D, Hu Y, et al. High-risk HPV16 E6 activates the cGMP/PKG pathway through glycosyltransferase ST6GAL1 in cervical cancer cells. Front Oncol. 2021;11:716246. doi: 10.3389/fonc.2021.716246.
   PubMed Web of Science ®Google Scholar
• Lv Y, Wang X, Li X, Xu G, Bai Y, Wu J, Piao Y, Shi Y, Xiang R, Wang L. Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway. PLoS Biol. 2020;18(11):e3000872. doi: 10.1371/journal.pbio.3000872.
   PubMed Web of Science ®Google Scholar
• Yang J, Liu X, Cao S, Dong X, Rao S, Cai K. Understanding esophageal cancer: the challenges and opportunities for the next decade. Front Oncol. 2020;10:1727. doi: 10.3389/fonc.2020.01727.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770–803. doi:10.1021/acs.jnatprod.9b01285.
   PubMed Web of Science ®Google Scholar
• Guo J, Zhang S, Wang J, Zhang P, Lu T, Zhang L. Hinokiflavone inhibits growth of esophageal squamous cancer by inducing apoptosis via regulation of the PI3K/AKT/mTOR signaling pathway. Front Oncol. 2022;12:833719. doi: 10.3389/fonc.2022.833719.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chu F, Lin J, Li Y, Johnson N, Zhang J, Gai C, Su Z, Cheng H, Wang L, et al. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification. J Ethnopharmacol. 2021;279:114399. doi: 10.1016/j.jep.2021.114399.
   PubMed Web of Science ®Google Scholar
• Hong P, Liu Q-W, Xie Y, Zhang Q-H, Liao L, He Q-Y, Li B, Xu WW. Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis. Cell Death Dis. 2020;11(7):524. doi:10.1038/s41419-020-2730-7.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang Y, Zhao D, Zhang L, Zhang W, Fan J, Li J, Zhan Q. Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC). Acta Pharm Sin B. 2021;11(1):143–55. doi: 10.1016/j.apsb.2020.07.011.
   PubMed Web of Science ®Google Scholar
• Yang A, Sun Z, Liu R, Liu X, Zhang Y, Zhou Y, Qiu Y, Zhang X. Transferrin-conjugated erianin-loaded liposomes suppress the growth of liver cancer by modulating oxidative stress. Front Oncol. 2021;11:727605. doi:10.3389/fonc.2021.727605.
   PubMed Web of Science ®Google Scholar
• Liu Y-T, Hsieh M-J, Lin J-T, Chen G, Lin C-C, Lo Y-S, Chuang Y-C, Hsi Y-T, Chen M-K, Chou M-C. Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma. Biomed Pharmacother. 2019;111:262–9. doi: 10.1016/j.biopha.2018.12.081.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Sheng Y, Li W, Wang J, Ma Y, Du B, Tang Y. Erianin, a novel dibenzyl compound in dendrobium extract, inhibits bladder cancer cell growth via the mitochondrial apoptosis and JNK pathways. Toxicol Appl Pharmacol. 2019;371:41–54. doi: 10.1016/j.taap.2019.03.027.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu H, Yang M, Bai Y, Ren H, Zou Y, Yao Z, Zhang B, Li Y. RNA-Seq based transcriptome analysis of endothelial differentiation of bone marrow mesenchymal stem cells. Eur J Vasc Endovasc Surg. 2020;59(5):834–42. doi: 10.1016/j.ejvs.2019.11.003.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li G, Zhou Q, Shao D, Lv J, Zhou J. Dual targeting of cell growth and phagocytosis by erianin for human colorectal cancer. Drug Des Devel Ther. 2020;14:3301–13. doi: 10.2147/DDDT.S259006.
   PubMed Web of Science ®Google Scholar
• Li N, Xi Y, Tinsley HN, Gurpinar E, Gary BD, Zhu B, Li Y, Chen X, Keeton AB, Abadi AH, et al. Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling. Mol Cancer Ther. 2013;12(9):1848–59. doi: 10.1158/1535-7163.MCT-13-0048.
   PubMed Web of Science ®Google Scholar
• Vighi E, Rentsch A, Henning P, Comitato A, Hoffmann D, Bertinetti D, Bertolotti E, Schwede F, Herberg FW, Genieser H-G, et al. New cGMP analogues restrain proliferation and migration of melanoma cells. Oncotarget. 2018;9(4):5301–20. doi: 10.18632/oncotarget.23685.
   PubMedGoogle Scholar
• Di Iorio P, Ronci M, Giuliani P, Caciagli F, Ciccarelli R, Caruso V, Beggiato S, Zuccarini M. Pros and cons of pharmacological manipulation of cGMP-PDEs in the prevention and treatment of breast cancer. IJMS. 2021;23(1):262. doi: 10.3390/ijms23010262.
   Web of Science ®Google Scholar
• Tuttle TR, Mierzwa ML, Wells SI, Fox SR, Ben-Jonathan N. The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma. Cancer Lett. 2016;370(2):279–85. doi: 10.1016/j.canlet.2015.10.024.
   PubMed Web of Science ®Google Scholar
• Xiang T, Yuan C, Guo X, Wang H, Cai Q, Xiang Y, Luo W, Liu G. The novel ZEB1-upregulated protein PRTG induced by helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway. Cell Death Dis. 2021;12(2):150. doi: 10.1038/s41419-021-03440-1.
   PubMed Web of Science ®Google Scholar
• Kong X, Wang JS, Yang H. Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway. J Biochem Mol Toxicol. 2021;35(6):1–11. doi: 10.1002/jbt.22749.
   PubMed Web of Science ®Google Scholar
• Burkhardt M, Glazova M, Gambaryan S, Vollkommer T, Butt E, Bader B, Heermeier K, Lincoln TM, Walter U, Palmetshofer A, et al. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem. 2000;275(43):33536–41. doi: 10.1074/jbc.M005670200.
   PubMed Web of Science ®Google Scholar
• Yu L-M, Dong X, Zhang J, Li Z, Xue X-D, Wu H-J, Yang Z-L, Yang Y, Wang H-S. Naringenin attenuates myocardial ischemia-reperfusion injury via cGMP-PKGIα signaling and in vivo and in vitro studies. Oxid Med Cell Longev. 2019;2019:7670854. doi: 10.1155/2019/7670854.
   PubMed Web of Science ®Google Scholar